In a strategic move which clearly underscores the potential for a substantial transformation of the European manufacturing business of Aryzta AG, the Irish-Swiss baked food group has recently announced its decision to acquire German bakery company Klemme AG in a €280 million ($376 million) deal.
The acquisition deal – which will include a 10 million-euro deferred payment and will be financed with Aryzta’s existing resources – marks the expansion of Zurich-based Aryzta in Germany.
In a statement pertaining to the Klemme takeover deal, Aryzta – the Swiss owner of bakery brands such as Delice de France and Otis Spunkmeyer – said that the move was consistent with the company’s policy of aiming at acquisitions “which add new geographies, customers, channels, and product capability.”
The acquisition of Klemme – which generated €229 million in annual revenue last year - is Aryzta’s biggest takeover since 2010. The takeover will make the group one of the foremost players in the growing in-store bakery sector in Germany.
About the Klemme acquisition, the Aryzta management said in a statement: “The acquisition enhances the defensive characteristics of the group’s business model in Europe as Aryzta will now manufacture an enhanced range of bakery products to meet consumer tastes across all channels.”
According to reports, Apple’s new Mac desktops and MacBooks running on the first version of the company’s new MacOS desktop operating system will likely be available from fall 2016.
The first version of MacOS is codenamed ‘Sierra.’
...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
During the course of Thursday proceedings in the ongoing legal scuffle between Google and Oracle...
Paying in cash is any day better than taking a loan from a loan shark. In good old days people used a wad of cash to pay everything starting from furniture to grocery, if they did not have enough, they would wait for something cheaper or for the...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google posted a video of a developer presentation to the Google Developers YouTube...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
During the course of Thursday proceedings at the VidCon...
During the course of a press event held in San Francisco...
According to reports, Apple’s new Mac desktops and...
Workplace chat service Slack has announced the rollout...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).